EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyse

Weight loss and asthma control: A systematic review of randomized controlled trials

Mahdieh Abbasalizad Farhangi iD, George Doumat, Isis F Baroni, Carlos A Camargo iD

Obesity Reviews · 2025

DOI: 10.1111/obr.13907 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Obesity Reviews, 2025. Verfasst von Mahdieh Abbasalizad Farhangi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community Nutrition, Faculty of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran. Hauptthemen laut MEDLINE: Asthma, Weight Loss, Obesity. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 73 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In the current systematic review and meta‐analysis, we evaluated the possible role of weight loss on asthma control, quality of life (QOL), and clinical outcomes among patients with asthma.

Methods

We performed a systematic search of PubMed, CINAHL, and OVID Medline for randomized controlled human trials that examined the effects of weight loss on asthma control, QOL, and spirometry results, from 1 January 2000 to 31 December 2023. Twelve eligible studies (total n = 1052 participants) were included. Weighted mean differences (WMD) and 95% confidence intervals (CIs) were used to evaluate the effect size. Subgroup analyses and meta‐regression approaches were performed to reveal possible sources of heterogeneity. Fractional polynomial modeling was performed to assess non‐linear associations.

Results

Weight loss reduced ACQ score (WMD −0.67 [95%CIs − 1.20, −0.13], P = 0.02; I 2 91.3%, P < 0.001), and improved forced expiratory volume percent predicted (FEV)1 pp (WMD 13.08 [95%CIs 2.42, 23.73], P = 0.02; I 2 94.1%, P < 0.001) among patients with asthma. In a dose–response analysis, a significant non‐linear association was reported between change in weight and changes in FEV1 pp (P non‐linearity = 0.01). The effects of weight loss on QOL (WMD 0.53 [−0.38, 1.44], P = 0.25; I 2 95.6%, P < 0.001) and forced vital capacity percent predicted (FVC pp , WMD 4.90 [−3.22, 13.02], P = 0.24; I 2 91.4%, P < 0.001) were not statistically significant.

Conclusion

Weight loss improves asthma control and FEV1 pp among patients with asthma in a two‐class meta‐analysis. Because of the relatively low number of well‐designed clinical trials (n = 12), further trials are needed to better define the beneficial effects of weight loss on asthma control.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AsthmaWeight LossObesityHumansRandomized Controlled Trials as TopicQuality of LifeForced Expiratory Volume

Stichwörter der Autor:innen

asthmaobesitysystematic reviewweight loss

Autor:innen und Institutionen

  • Department of Community Nutrition, Faculty of Nutrition, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Department of Emergency Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.

ORCID-Profile: Mahdieh Abbasalizad Farhangi, Carlos A Camargo

Zitieren

APA

Farhangi, M. A., Doumat, G., Baroni, I. F., & Camargo, C. A. (2025). Weight loss and asthma control: A systematic review of randomized controlled trials. Obesity Reviews. https://doi.org/10.1111/obr.13907

Vancouver

Farhangi MA, Doumat G, Baroni IF, Camargo CA. Weight loss and asthma control: A systematic review of randomized controlled trials. Obesity Reviews. 2025. doi:10.1111/obr.13907

BibTeX
@article{Farhangi2025,
  author = {Farhangi, Mahdieh Abbasalizad and Doumat, George and Baroni, Isis F and Camargo, Carlos A},
  title = {Weight loss and asthma control: A systematic review of randomized controlled trials},
  journal = {Obesity Reviews},
  year = {2025},
  doi = {10.1111/obr.13907}
}
Kostenlos starten →